FZ 001
Alternative Names: FZ-001Latest Information Update: 28 Jun 2023
At a glance
- Originator Guangzhou Fermion Technology
- Class Anti-inflammatories; Antirheumatics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Atopic dermatitis; Rheumatoid arthritis
Most Recent Events
- 23 Jun 2023 Preclinical trials in Atopic dermatitis in China (unspecified route) prior to June 2023 (Guangzhou Fermion Technology, June 2023)
- 23 Jun 2023 Preclinical trials in Rheumatoid arthritis in China (unspecified route) prior to June 2023 (Guangzhou Fermion Technology, June 2023)